LAB

Labrador Gold launches a strategic review with no concrete actions or financial details disclosed.

Labrador Gold appoints new President and Corporate Secretary, highlights key project metrics.

Labrador Gold raised $5.76 million in a private placement to fund Canadian exploration.

Labrador Gold extends its private placement, raising $2.13M so far toward a $7M target.

Labrador Gold raises $2.13M in first tranche, upsizes placement to $7M.

Labrador Gold upsizes private placement to $7 million with strong lead investor backing.

Standard BioTools is selling its Microfluidics business to ARCHIMED; terms undisclosed.

Labrador Gold seeks $2–4 million in imminent private placement led by major mining investors.

Losses persist despite margin gains; merger and divestiture drive near-term uncertainty.

This is an early-stage exploration update with little near-term investment impact or hard data.

Permit secured, but all real progress and value remain unproven and in the future.

This is a high-risk, early-stage Yukon gold bet with no near-term payoff.

Operational progress is real, but profitability and growth remain unproven and mostly aspirational.